ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

Clearinghouse Subgroup asks For Tests On Three Chemicals

October 7, 1977

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009